Schmitz M Lienhard, Mattioli Ivan, Buss Holger, Kracht Michael
University of Bern, Department of Chemistry and Biochemistry, Freiestrasse 3, 3012 Bern, Switzerland.
Chembiochem. 2004 Oct 4;5(10):1348-58. doi: 10.1002/cbic.200400144.
NF-kappaB is a generic name for an evolutionarily conserved transcription-factor system that contributes to the mounting of an effective immune response but is also involved in the regulation of cell proliferation, development, and apoptosis. The implication of NF-kappaB in central biological processes and its extraordinary connectivity to other signaling pathways raise a need for highly controlled regulation of NF-kappaB activity at several levels. While all NF-kappaB activation pathways share a central and critical proteasome-mediated step that leads to the degradation of inhibitory proteins and the release of DNA-binding subunits, there is evidence for a downstream level of NF-kappaB regulation that employs several mechanisms. These include promoter-specific exchange of dimers and modification of the transactivating p65 subunit by phosphorylation, acetylation, ubiquitination, or prolyl isomerization. The signaling pathways and enzymes controlling this second level of regulation and their potential use as therapeutic targets for the treatment of NF-kappaB-associated pathologies are discussed here.
核因子-κB(NF-κB)是一种在进化上保守的转录因子系统的统称,它有助于产生有效的免疫反应,但也参与细胞增殖、发育和凋亡的调控。NF-κB在核心生物学过程中的作用及其与其他信号通路的特殊联系,使得需要在多个层面上对NF-κB活性进行高度可控的调节。虽然所有NF-κB激活途径都有一个核心且关键的蛋白酶体介导步骤,该步骤导致抑制蛋白降解和DNA结合亚基释放,但有证据表明存在一个下游的NF-κB调节水平,该水平采用多种机制。这些机制包括二聚体的启动子特异性交换以及通过磷酸化、乙酰化、泛素化或脯氨酰异构化对转录激活p65亚基进行修饰。本文讨论了控制这一第二调节水平的信号通路和酶及其作为治疗NF-κB相关疾病治疗靶点的潜在用途。